![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual |
| Neoplasms of the CNS |
|
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Neoplasms of the CNS is free of charge.
Contributing Factors to Delay of Adjuvant Postsurgical Radiation for Malignant
Brain Tumors: A Single Institution Experience in a Rural State.
Am J Clin Oncol. 2025 Nov 20. doi: 10.1097/COC.0000000000001266.
PubMed
Abstract available
Adjuvant chemoradiotherapy with procarbazine, lomustine, and vincristine (PCV) or
temozolomide for 1p/19q Co-deleted anaplastic oligodendroglioma: a systematic
review and network meta-analysis.
BMC Cancer. 2025;25:1779.
PubMed
Abstract available
Comparative analysis of the outcomes of craniotomy and endoscopic resection for
recurrent craniopharyngioma: a single institution study.
BMC Cancer. 2025;25:1781.
PubMed
Abstract available
A nomogram for breast cancer brain metastasis patients after stereotactic
radiotherapy.
BMC Cancer. 2025;25:1784.
PubMed
Abstract available
Contralateral transcallosal transfalcine approach for bilateral
intra-extraventricular anaplastic ganglioglioma via 'the trans-tumoral route': a
technical case instruction.
Br J Neurosurg. 2025;39:832-837.
PubMed
Abstract available
Rethinking the role of surgical resection in the management of primary pituitary
lymphoma.
Br J Neurosurg. 2025;39:844-848.
PubMed
Abstract available
Craniopharyngioma in children. An age-based analysis on our 11 year experience
with the endoscopic endonasal approach.
Childs Nerv Syst. 2025;41:367.
PubMed
Abstract available
ETV for fourth ventricle outlet obstruction (FVOO) in the long-term period
following pediatric posterior fossa tumor resection.
Childs Nerv Syst. 2025;41:366.
PubMed
Abstract available
Neuro-ophthalmic clues affecting the surgical approach to a brain tumor: the case
of a craniopharyngioma masquerader.
Childs Nerv Syst. 2025;41:361.
PubMed
Abstract available
Molecular subtype prediction model for pediatric low-grade gliomas using
conventional neuroradiology reporting.
Childs Nerv Syst. 2025;41:355.
PubMed
Abstract available
Post-ablation volume threshold for brain metastasis control using LITT: a
systematic review and critical appraisal.
J Neurooncol. 2025;176:85.
PubMed
Abstract available
China National Glioma Registry (CNGR): protocol for a prospective observational
registry study.
J Neurooncol. 2025;176:83.
PubMed
Abstract available
GLIMMER: an interim subgroup analysis from an ongoing prospective study
evaluating hyperspectral imaging for MGMT promoter methylation in gliomas.
J Neurooncol. 2025;176:86.
PubMed
Abstract available
Immunohistochemistry markers of molecular subtype do not correlate with the
growth behaviour for recurrent meningiomas - a cohort study.
J Neurooncol. 2025;176:94.
PubMed
Tumor-associated M2 macrophages shape the cerebrospinal fluid immunoprofile, and
the soluble CD163/type I interferon ratio correlates with prognosis in high grade
glioma.
J Neurooncol. 2025;176:93.
PubMed
Abstract available
Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E
mutated papillary craniopharyngioma: a systematic review.
J Neurooncol. 2025;176:90.
PubMed
Clinical and genomic characterization of brain metastasis in thyroid cancer.
J Neurooncol. 2025;176:87.
PubMed
Abstract available
Performance of artificial intelligence for brain tumor segmentation, treatment
planning, and outcome prediction: a comprehensive systematic review and
meta-analysis.
J Neurooncol. 2025;176:88.
PubMed
Seizure characteristics in epilepsy patients with a primary brain tumor.
J Neurooncol. 2025;176:92.
PubMed
Effects of temozolomide dosing on outcome in glioblastoma.
J Neurooncol. 2025;176:89.
PubMed
Abstract available
Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas.
J Neuropathol Exp Neurol. 2025 Nov 20:nlaf131. doi: 10.1093.
PubMed
Abstract available
A framework for using DNA methylation-based modelling for the clinical management
of cranial meningioma.
Neuro Oncol. 2025 Nov 19:noaf237. doi: 10.1093.
PubMed
Abstract available
Opposing Functions of White Matter in Glioblastoma.
Neuro Oncol. 2025 Nov 14:noaf266. doi: 10.1093.
PubMed
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single
time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.
Neuro Oncol. 2025 Nov 13:noaf261. doi: 10.1093.
PubMed
Abstract available
Cross-modality image-to-image translation from MR to synthetic (18)F-FDOPA PET/MR
fusion images using conditional GAN in brain cancer.
Neuroradiology. 2025;67:2727-2740.
PubMed
Abstract available
MRI-based interpretable clinicoradiological and radiomics machine learning model
for preoperative prediction of pituitary macroadenomas consistency: a dual-center
study.
Neuroradiology. 2025 Jul 9. doi: 10.1007/s00234-025-03698.
PubMed
Abstract available
Superselective anterior choroidal artery preoperative embolization of a giant
choroid plexus carcinoma in an infant: case report and systematic review.
Neuroradiology. 2025;67:2939-2947.
PubMed
Abstract available
The Role of the Neurologist in the Management of Pediatric Central Nervous System
Tumors, From Diagnosis to Long-Term Follow-Up.
Pediatr Neurol. 2025;173:142-148.
PubMed
Abstract available
The blood-brain barrier regulates brain tumor growth through the SLC36 amino acid
transporter Pathetic in Drosophila.
PLoS Biol. 2025;23:e3003496.
PubMed
Abstract available
Anethole inhibits human U87 Glioma cell proliferation by inducing apoptosis via
the PI3K/AKT pathway.
PLoS One. 2025;20:e0336975.
PubMed
Abstract available
Correction: Linalool-based silver nanoconjugates as potential therapeutics for
glioblastoma: in silico and in vitro insights.
PLoS One. 2025;20:e0336814.
PubMed
Abstract available
Improved brain tumor diagnostics and follow-up with novel magnetic resonance
imaging methods: A single center study protocol.
PLoS One. 2025;20:e0336387.
PubMed
Abstract available
Correction for Goyette et al., Cancer-stromal cell interactions in breast cancer
brain metastases induce glycocalyx-mediated resistance to HER2-targeting
therapies.
Proc Natl Acad Sci U S A. 2025;122:e2530590122.
PubMed
Thank you for your interest in scientific medicine.